Skip to Main Content

Advertisement

Skip Nav Destination

Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients

J Exp Med (2004) 200 (3): 297–306.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal